These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335 [TBL] [Abstract][Full Text] [Related]
8. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247 [TBL] [Abstract][Full Text] [Related]
9. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Kent SJ; Fernandez CS; Dale CJ; Davenport MP Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? O'Connor D; Allen T; Watkins DI Immunol Lett; 2001 Nov; 79(1-2):77-84. PubMed ID: 11595292 [TBL] [Abstract][Full Text] [Related]
12. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection. Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S mBio; 2017 May; 8(3):. PubMed ID: 28465428 [TBL] [Abstract][Full Text] [Related]
13. Rates of HIV immune escape and reversion: implications for vaccination. Davenport MP; Loh L; Petravic J; Kent SJ Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018 [TBL] [Abstract][Full Text] [Related]
14. Research progress on HIV-1 immune escape mechanisms. Meng Y; Zhong J; Lv Y; Zou W AIDS Rev; 2022 Oct; 24(3):133-138. PubMed ID: 35504029 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of viral evolution and CTL responses in HIV-1 infection. Liu Y; McNevin JP; Holte S; McElrath MJ; Mullins JI PLoS One; 2011 Jan; 6(1):e15639. PubMed ID: 21283794 [TBL] [Abstract][Full Text] [Related]
16. Immuno-epidemiological modeling of HIV-1 predicts high heritability of the set-point virus load, while selection for CTL escape dominates virulence evolution. van Dorp CH; van Boven M; de Boer RJ PLoS Comput Biol; 2014 Dec; 10(12):e1003899. PubMed ID: 25522184 [TBL] [Abstract][Full Text] [Related]
17. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 mutates to adapt in fluxing environments. Nomaguchi M; Doi N; Koma T; Adachi A Microbes Infect; 2018; 20(9-10):610-614. PubMed ID: 28859896 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage. Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298 [TBL] [Abstract][Full Text] [Related]
20. Virological features associated with the development of broadly neutralizing antibodies to HIV-1. Moore PL; Williamson C; Morris L Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]